XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities    
Net income $ 34,701 $ 50,674
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 3,230 2,565
Amortization of intangible assets 5,345 6,185
Amortization of original issue discount 452 616
Amortization of deferred financing costs 751 561
Amortization of unrealized loss on interest rate swaps 0 1,002
Loss on extinguishment of debt 0 1,839
Provision for losses on accounts receivable 67 225
Deferred income taxes 12,606 20,075
Loss on disposal of property and equipment 62 2
Share-based compensation expense 3,322 2,931
Net changes in operating assets and liabilities:    
Accounts receivable (17,324) (34,648)
Inventories 7,931 (33,007)
Other assets 369 13
Accounts payable 4,459 22,601
Accrued wages and employee benefits (11,557) (3,358)
Other accrued liabilities (1,533) 7,684
Excess tax benefits from equity awards (6,528) (7,694)
Net cash provided by operating activities 36,353 38,266
Investing activities    
Proceeds from sale of property and equipment 6 0
Expenditures for property and equipment (4,925) (4,322)
Net cash used in investing activities (4,919) (4,322)
Financing activities    
Proceeds from short-term borrowings 4,000 0
Repayments of short-term borrowings (6,571) (18)
Repayments of long-term borrowings and capital lease obligations (3,326) (82,250)
Payment of debt issuance costs (4) 0
Cash dividends paid for restricted stock upon vesting (334) (2,649)
Taxes paid related to the net share settlement of equity awards (8,152) (10,417)
Excess tax benefits from equity awards 6,528 7,694
Net cash used in financing activities (7,859) (87,640)
Effect of exchange rate changes on cash and cash equivalents 18 10
Net increase (decrease) in cash and cash equivalents 23,593 (53,686)
Cash and cash equivalents at beginning of period 150,147 108,023
Cash and cash equivalents at end of period $ 173,740 $ 54,337